SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

REMEDIUM LIFECARE

BSE: 539561 19 Aug 2025
Services
₹ 1.31
REMEDIUM LIFECARE LIMITED specializes in Trading & Distributors within the Services sector.

REMEDIUM LIFECARE - Share Price & Details

Market Cap
₹114.0
High /Low
40.6 / 0.8
Stock P/E
74.4
Book Value
₹0.48
Dividend Yield
0.0
ROCE
1.39
ROE
₹3.55
Face Value
1.0
PEG Ratio
6.04
EVEBITDA
₹139.0
Debt
1,141
CMP / FCF
-0.3
Debt to equity
₹26.4
NP Ann
1.53
High price all time
132.0
Piotroski score
₹3.0
Graham Number
0.43
No. Eq. Shares
88.2
Net CF
₹-0.16
Net profit
1.53
Price to book value
2.67
Interest Coverage
₹1.69
Low price all time
0.29
Industry PE
32.8
Reserves
₹2.98
Free Cash Flow
₹-1,079

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
Alna Trading & Exports Ltd.,21.120.5921.122.960
Oseaspre Consultants Ltd.,1.861.431.807.130
REMEDIUM LIFECARE LIMITED822.29-26.43815.69-0.07114.074.4
TCI INDUSTRIES LTD.11.41-8.6010.99-9.58112
GENPHARMASEC LIMITED146.16-2.27135.56-0.0111246.3

Peer Comparison Chart


About REMEDIUM LIFECARE

REMEDIUM LIFECARE LIMITED, with Security Code 539561, is a leading player in the Trading & Distributors industry, categorized under the Services sector, offering Equity instruments.


Latest News

Remedium Lifecare Kicks Off FY26 with ₹464.88 Lakh PAT in Q1, Surpassing and Doubling FY25 Profit in Q1 and Driving Expansion Plans

(12 Aug 2025)
Q1FY26 PAT up by 327% at 464.88 lakhs compared to loss of 204.60 lakhs in Q4FY25 • Q1FY26 PAT at 464.88 lakhs against entire FY25 PAT of 212.94 lakhs.
Read more →

Remedium Lifecare Posts Rs 4.64 Cr Q1 FY26 PAT, Over 2x FY25 Q1 Profit, Fuelling Growth & Expansion Plans

(11 Aug 2025)
Mumbai (Maharashtra) [India], August 11: Remedium Lifecare Ltd., a rapidly growing player in the pharmaceutical supply chain and speciality...
Read more →

Remedium Lifecare Reports Significant Financial Decline, Adjusts Evaluation Amid Challenges

(06 Aug 2025)
Remedium Lifecare has announced its financial results for the quarter ending June 2025, revealing a significant decline in net sales and profitability.
Read more →

Remedium Lifecare Limited (539561)’s Trend in 2025 - Free Stock Market Mentorship

(24 Jul 2025)
Remedium Lifecare Limited (539561)'s Trend in 2025 ✌️【Investment Insights】✌️ Thousands trust our system to find opportunities with huge...
Read more →

Remedium Lifecare Limited (539561) to Launch New Product Line - Superior stock selection

(23 Jul 2025)
Remedium Lifecare Limited (539561) to Launch New Product Line ✌️【Stock Highlights】✌️ Our members enjoy access to high-conviction investment...
Read more →

Remedium Lifecare Limited Charts Long-Term Growth with Global Subsidiary, Export Contract and Strong Investor Support

(23 Jul 2025)
Mumbai, 22 July 2025: Remedium Lifecare Limited (“Remedium”), a strategically positioned and fast-growing player in the Pharma Trade and...
Read more →

Company Updates